Substituted acetophenones useful as PDE4 inhibitors

Details for Australian Patent Application No. 2012203892 (hide)

Owner LEO Pharma A/S

Inventors Nielsen, Simon Feldbaek; Felding, Jakob

Agent Callinan

Pub. Number AU-A-2012203892

Parent 2007336538

Filing date 3 July 2012

Wipo publication date 19 July 2012

International Classifications

C07D 213/61 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 - Non-condensed pyridines

A61K 31/4427 - containing further heterocyclic ring systems

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203892

19 July 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203893-Synchronization of wireless catheters

2012203891-Body parameter detecting sensor and method for detecting body parameters